Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE (ABBV)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summaryMarketScreener Strategies
OFFRE
Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Weaknesses
  • The company is in debt and has limited leeway for investment
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
  • Based on current prices, the company has particularly high valuation levels.
  • The underlying tendency is negative on the weekly chart below the resistance at 105.98 USD
Ratings chart
Sector Specialty & Advanced Pharmaceuticals
1st jan.Capitalisation (M$)Investor Rating
ABBVIE-1.39%144 416
MERCK KGAA-3.22%12 981
KYOWA HAKKO KIRIN CO LTD-9.41%10 350
JAZZ PHARMACEUTICALS PLC19.58%9 851
ZHANGZHOU PIENTZEHUANG PHAR..43.39%8 109
CONVATEC GROUP12.51%5 868
YUHAN CORP--.--%2 664
MALLINCKRODT PLC31.52%2 647
REPLIGEN CORPORATION62.54%2 583
SUPERNUS PHARMACEUTICALS IN..15.43%2 551
INDIVIOR-36.21%2 539
BETTA PHARMACEUTICALS CO LT..--.--%2 212
AIMMUNE THERAPEUTICS INC-25.70%1 708
MITHRA PHARMACEUTICALS209.94%1 505
THERAPEUTICSMD INC1.66%1 487
KISSEI PHARMACEUTICAL CO LT..-1.54%1 479
More Results
Financials ($)
Sales 2018 32 862 M
EBIT 2018 14 513 M
Net income 2018 10 305 M
Debt 2018 29 518 M
Yield 2018 3,85%
P/E ratio 2018 14,32
P/E ratio 2019 12,32
EV / Sales 2018 5,29x
EV / Sales 2019 4,94x
Capitalization 144 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart ABBVIE
Duration : Period : Day
AbbVie Technical Analysis Chart | MarketScreener
Duration : Period : Week
AbbVie Technical Analysis Chart | MarketScreener